BioMers Series B financing
With FDA 510k, CE, HSA, Malaysia FDA approvals.
Strong project team mixed with marketing and technology specialists.
Strong IP and sustainable technology roadmap.
BioMers is a Singapore based medical device company specialized in material application in orthodontic treatment, its flagship product, SimpliClear, is a transparent, custom, fixed orthodontic treatment appliance. The manufacturing process involves intraoral scan, AI product design, 3D printing and manufacturing automation. SimpliClear promotes aesthetic, patient comfort and shorter chair-side time. With SimpliClear, caregiver is able to treat patient more accurate, faster and simple. It has received regulators' approval, such as US FDA, EU CE, Singapore HSA, Malaysia FDA and more. It won many international startup competitions.